Azurrx biopharma, inc. (AZRX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15
Research and development expenses

1,553

722

2,210

2,738

3,009

1,998

1,168

925

1,678

151

966

743

534

225

744

840

685

363

General and administrative expenses

1,375

403

1,871

2,193

1,593

2,049

1,317

2,167

1,916

2,120

2,009

1,381

2,174

2,039

543

884

661

1,044

Fair value adjustment, contingent consideration

-

-

0

0

-

30

-80

-170

10

-30

250

-260

-100

1,200

-900

0

0

0

Loss from operations

-2,928

-

-4,082

-4,932

-4,603

-

-2,566

-3,263

-3,584

-2,302

-2,726

-2,384

-2,808

-1,064

-2,188

-1,724

-1,347

-1,408

Other:
Interest expense

2,332

155

110

110

57

1

5

46

48

178

408

287

0

4,110

724

388

713

520

Fair value adjustment, warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-455

-285

-1,657

69

55

Total other

2,332

155

110

110

57

1

5

46

48

178

408

287

0

4,566

1,010

2,045

644

464

Loss before income taxes

-5,261

-

-4,192

-5,042

-4,660

-

-2,571

-3,309

-3,632

-

-3,134

-2,671

-2,809

-5,631

-3,198

-3,770

-1,991

-1,873

Income taxes

0

-

0

0

0

-

0

0

0

-

0

0

0

0

0

0

0

0

Net loss

-5,261

-1,281

-4,192

-5,042

-4,660

-4,019

-2,571

-3,309

-3,632

-2,481

-3,134

-2,671

-2,809

-5,631

-3,198

-3,770

-1,991

-1,873

Other comprehensive loss:
Foreign currency translation adjustment

157

90

-138

26

-95

-54

-36

-209

106

-224

439

230

61

-248

63

-125

194

96

Total comprehensive loss

-5,103

-1,191

-4,330

-5,016

-4,756

-4,074

-2,607

-3,519

-3,526

-2,706

-2,694

-2,441

-2,747

-5,879

-3,134

-3,896

-1,796

-1,777

Basic and diluted weighted average shares outstanding

26,941

-63,162

24,962

20,479

17,719

-44,637

16,889

15,300

12,447

11,576

11,242

10,064

9,631

9,264

6,028

5,999

4,725

3,587

Loss per share - basic and diluted

-0.20

22,425,564.68

-0.17

-0.25

-0.26

15,439,310.66

-0.15

-0.22

-0.29

-0.20

-0.28

-0.27

-0.29

-0.66

-0.53

-0.63

-0.42

-0.52